Category: Philips Healthcare
Here's a look at some of the top Wall Street stories for medical device companies this week: Smith & Nephew CEO reveals new 'no frills' strategy; Bard: We're on track for early 2015 Lutonix approval; Ocular Therapeutix prices IPO below range; Philips' healthcare business suffers in Q2; Intersect ENT prices IPO at low end of range
Sluggish healthcare sales drag down Philips overall figures, but the company is eying a comeback for the 2nd half of the year.
Philips Healthcare (NYSE:PHG) had a tough 2nd quarter with a shutdown of a manufacturing facility in Cleveland taking some of the wind out of the sales for the entire company.
Charles Dockendorff, the outgoing CFO at Covidien, is named to the board of directors at Haemonetics.
, BSD Medical
, Invacare Corp.
, Life Sciences Foundation
, Oncologix Tech Inc.
, Philips Healthcare
, Reva Medical Inc.
Bruce Shook, the co-founder & former CEO of Neuronetics and the ex-president of Abiomed, is named CEO of Intact Vascular.
Intact Vascular said yesterday that it named medical device veteran Bruce Shook as its new president & CEO.
FDA inspectors say that Philips cut corners at a manufacturing facility that makes infant sleep apnea devices that were recalled due to battery issues.
Philips Healthcare's (NYSE:PHG) Respironics unit is in the FDA's cross-hairs after regulators inspected a manufacturing facility responsible for infant sleep apnea monitors that were the subject of a recall.
Here's a look at some of the top Wall Street stories for medical device companies this week: T2 Biosystems prepares $69M IPO for MRI-based diagnostics; Philips Healthcare retools, CEO DiSanzo is out; iRadimed sets terms for $10M IPO
Philips Healthcare CEO Deborah DiSanzo is out as the Dutch conglomerate retools after reporting lower-than-expected 2nd-quarter earnings for its healthcare business.